GGINX | RGFTX | GGINX / RGFTX | |
Total Expense Ratio | 0.97 | 0.91 | 107% |
Annual Report Gross Expense Ratio | 1.34 | 1.24 | 108% |
Fund Existence | 9 years | 9 years | - |
Gain YTD | 14.829 | 19.732 | 75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 102M | 354M | 29% |
Annual Yield % from dividends | 1.81 | 3.06 | 59% |
Returns for 1 year | -2.56 | 12.05 | -21% |
Returns for 3 years | 28.27 | 47.00 | 60% |
Returns for 5 years | 28.29 | 28.84 | 98% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSMEX | 60.11 | 0.14 | +0.23% |
Fidelity Select Medical Tech and Devcs | |||
FQTEX | 13.60 | 0.03 | +0.22% |
Franklin Templeton SMACS: Series E Adv | |||
JLGRX | 95.42 | 0.19 | +0.20% |
JPMorgan Large Cap Growth R5 | |||
CPECX | 21.77 | -0.01 | -0.05% |
Catalyst Dynamic Alpha C | |||
MSKLX | 13.39 | -0.05 | -0.37% |
Morgan Stanley Inst Discovery L |